Established Shenzhen office, China, launching global expansion.
2011
•
Achieved $10M in Exports; Received Presidential Award (KITA).
2012~2015
2012~2015
2012~2015
2012
•
Established Tokyo office, Japan.
2013
•
Established Taiwan office.
•
Achieved $20M in Exports.
2014
•
Established Shanghai office.
•
OIS technology designated as a World-Class Product of Korea.
2015
•
Listed on KOSDAQ.
2016~2019
2016~2019
2016~2019
2016
•
Named Forbes 'Asia's 200 Best Under a Billion.
•
Selected for 'World Class 300'.
•
Awarded the Sunny Optical Technology Innovation Award.
•
Achieved $30M in Exports.
2017
•
Named KOSDAQ Rising Star.
2018
•
Secured foundational Korean patent for saliva-based diagnostic
technology.
2019
•
Recognized as an Excellent Supplier by Sunny Optical Technology
•
Expanded global patent portfolio for saliva diagnostics, securing rights
in Japan and India.
2020~2025
2020~2025
2020~2025
2020
•
Secured patent for saliva-based diagnostic technology in China.
2021
•
Selected for National R&D project (Strategic K-Fabless Technology).
2022
•
Presented D-SaLife system research at the 58th EASD Annual Meeting.
•
Named a World Class Product of Korea (OIS) by KOTRA
2023
•
Selected for a Government-Funded National R&D Project for the Development
of a Saliva-Based Glucose Monitoring Device
•
Secured European patent for saliva diagnostics
•
Registered a Korean Patent for an AI-Based Blood Glucose Prediction
System and Method
2024
•
Achieved $70M in Exports, marking continued global growth.
2025
•
Establishment of R&D center in Japan.
Company Name : Dongwoon Anatech Co., Ltd. CEO : Kim, Dong Cheol Address : 13F, Seocho Pyeonghwa Building, 22 Banpo-daero, Seocho-gu, Seoul, Republic of Korea
Company Name : Dongwoon Anatech Co., Ltd. | CEO : Kim, Dong Cheol Address : 13F, Seocho Pyeonghwa Building, 22 Banpo-daero, Seocho-gu, Seoul, Republic of Korea
